Insider Selling Continues in a Volatile Market
On February 3 2026, Susan Ocampo, acting as trustee for several family trusts, sold 100 000 shares of MACOM Technology Solutions Holdings Inc. at an average price of $230.29. The trade, recorded under SEC form 4, was executed against a backdrop of a modest 0.06 % rise in the stock price and a 85 % surge in social‑media buzz, indicating heightened investor attention to the company’s performance. Although the sale is small relative to Ocampo’s total holdings—over 4.3 million shares—the move is part of a series of transactions that have seen her divest roughly 700 000 shares during 2025, reducing her stake from 4.7 million to 4.4 million shares.
What Does This Mean for Investors?
Insider selling, especially in a company with a high price‑earnings ratio of 111.9, can signal management’s belief that the share price is overvalued or that cash needs are pressing. In MACOM’s case, the sale aligns with a broader pattern of selling among senior executives—including SVP Hwang Donghyun Thomas and CEO Stephen G. Daly—who collectively off‑loaded more than 1.5 million shares in 2025. The cumulative effect suggests that insiders are looking to diversify or fund personal commitments rather than a strategic divestiture of equity in a growth‑oriented semiconductor firm.
For investors, the key takeaway is that insider sales should be read in context. MACOM’s fundamentals remain solid: a 52‑week high of $236.8, a market cap of $16.1 billion, and a strong 32.6 % monthly gain. The company’s earnings guidance and gross‑margin trajectory will be closely watched, as analysts anticipate a potential uptick in data‑center demand that could lift margins in the next quarter. Until an earnings report or strategic announcement emerges, the current insider activity is unlikely to precipitate a significant price swing.
Ocampo’s Historical Trading Patterns
Susan Ocampo’s transaction history reveals a disciplined, incremental selling approach. Beginning in late October 2025, she sold blocks ranging from 44,000 to 124,000 shares at prices between $138 and $150. In December 2025, she accelerated the pace, selling 121,067 shares at $190.07, followed by 95,829 shares at $180.06, and 76,642 shares at $190.10. These trades were spaced over a few days, suggesting a strategy of averaging down the sale price while avoiding a sudden market impact.
Notably, Ocampo’s trades have been largely price‑matched to the prevailing market, with average prices hovering just above the current close in December (≈$181). Her latest February sale at $230.29 reflects a significant premium to the close ($215.03), indicating either a confidence in MACOM’s upward trajectory or a desire to capture excess liquidity. The fact that she is a trustee for trusts benefiting her children underscores a family‑centric investment approach, potentially aiming to lock in gains for future generations.
Investor Takeaway
While insider sales can be a red flag, they can also reflect routine portfolio management. For MACOM, the evidence points to a measured, incremental divestiture rather than an urgent cash need. Coupled with the company’s robust quarterly performance and a bullish analyst outlook, the insider activity is likely to be viewed as a routine transaction. Investors should monitor the upcoming earnings release for any shift in guidance or margin trends that could alter the narrative.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-02-03 | OCAMPO SUSAN () | Sell | 100,000.00 | 230.29 | Common Stock |
| N/A | OCAMPO SUSAN () | Holding | 2,577,334.00 | N/A | Common Stock |
| N/A | OCAMPO SUSAN () | Holding | 938,631.00 | N/A | Common Stock |




